(Q33362483)

English

Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group (English)

1 reference

Europe PubMed Central

26 July 2017

1 reference

based on heuristic

inferred from title

bladder carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Athanasios Dimopoulos

object named as

Meletios Athanasios Dimopoulos

8

0 references

author name string

Helena Linardou

1

1 reference

Europe PubMed Central

26 July 2017

Gerassimos Aravantinos

2

1 reference

Europe PubMed Central

26 July 2017

Eleni Efstathiou

3

1 reference

Europe PubMed Central

26 July 2017

Charalambos Kalofonos

4

1 reference

Europe PubMed Central

26 July 2017

Athanasios Anagnostopoulos

5

1 reference

Europe PubMed Central

26 July 2017

Charalambos Deliveliotis

6

1 reference

Europe PubMed Central

26 July 2017

Dimitrios Bafaloukos

7

1 reference

Europe PubMed Central

26 July 2017

Aristotelis Bamias

9

1 reference

Europe PubMed Central

26 July 2017

Phase II study of Hellenic Co-operative Oncology Group

10

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

64

1 reference

Europe PubMed Central

26 July 2017

479-484

1 reference

Europe PubMed Central

26 July 2017

3

1 reference

Europe PubMed Central

26 July 2017

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Carboplatin-based chemotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Management of cancer in the older person: a practical approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.04.024

7 January 2021

Identifiers

10.1016/J.UROLOGY.2004.04.024

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33362483&oldid=1971071964"